我武生物(300357.SZ)：获得狗毛皮屑点刺液药物临床试验补充申请批准通知书

Core Viewpoint - The company Iwubio (300357.SZ) has received approval for a supplementary application for clinical trials of its drug "Dog Dander Skin Prick Solution" from the National Medical Products Administration, indicating progress in its product development for diagnosing type I hypersensitivity diseases related to dog dander [1] Group 1 - The clinical trial supplementary application for the drug has been approved [1] - The drug is intended for use in skin prick tests to assist in diagnosing type I hypersensitivity diseases associated with dog dander [1]